Impact of Bright Light Therapy on Prader-Willi Syndrome
Recruiting
N/A
Interventional Study
Prader-Willi Syndrome
Excessive Daytime Sleepiness
Hyperphagia
Body Weight
Mood
Behavior
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 6 – 88
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Maimonides Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of PWS confirmed by genetic testing
* Score of 12 or above on the Epworth Sleepiness Scale (ESS).
Exclusion Criteria:
* Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients ne…
Contacts